Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
17.98 USD | +0.08% | -5.71% | -21.88% |
05-10 | UBS Adjusts Privia Health Group Price Target to $26.50 From $29, Maintains Buy Rating | MT |
05-09 | Transcript : Privia Health Group, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.88% | 2.14B | |
+17.56% | 85.55B | |
-28.34% | 70.07B | |
+6.76% | 28.95B | |
-7.31% | 17.51B | |
+2.14% | 17.39B | |
+1.85% | 15.38B | |
+6.40% | 13.4B | |
+65.80% | 12.93B | |
+6.64% | 12.77B |
- Stock Market
- Equities
- PRVA Stock
- News Privia Health Group, Inc.
- JMP Securities Initiates Privia Health Group With Market Outperform Rating, Price Target is $27